Featured Products

Upcoming Conventions & Events

  • November 29-December 3, 2009

    Radiological Society of North America (RSNA)

    Location: Chicago, Illinois

    We are your comprehensive imaging partner—providing the solutions and knowledge to help physicians make accurate diagnoses to aid in better patient outcomes.

  • Please note important safety updates for Optimark™ (gadoversetamide injection), effective November 6, 2009.

    Click here for 11/6/09 updated boxed warning and important safety information

    Click here for 11/6/09 Optimark DHCP letter

    All barium products and accessories will be discontinued effective January 15, 2010. Please see the attached customer letter for details regarding the discontinuation of these products.

    Customer Letter

    Covidien Responds to Molybdenum 99 Supply Shortage

    Click here for current information www.covidien.com/Mo99supply

  • 1/26/2009 7:01:00 AM

    B&W and Covidien to Develop U.S. Source of Key Medical Isotope

    Initiative could supply 50 percent of U.S. demand LYNCHBURG, Va. & ST. LOUIS--(BUSINESS WIRE)--Jan. 26, 2009--Babcock & Wilcox Technical Services Group, Inc. (B&W TSG), a major operating unit of The Babcock & Wilcox Company (B&W), has signed an agreement with Covidien (NYSE:COV, BSX: COV) to develop technology for the manufacture of molybdenum-99 (Mo-99), the p…

  • 9/28/2009 7:01:00 AM

    Covidien Announces Definitive Agreement to Acquire Aspect Medical Systems, Inc.

    DUBLIN, Ireland & NORWOOD, Mass., Sep 28, 2009 (BUSINESS WIRE) -- Covidien (NYSE: COV) and Aspect Medical Systems, Inc. (NASDAQ: ASPM) today announced that Covidien has reached a definitive agreement to acquire Aspect, a global market leader in brain monitoring technology. The Boards of Directors of both companies have unanimously approved the transaction, pursuant to which a wholly owned subsidiary of Covidien will pay $12.00 in cash per Aspect share for a to…

  • 9/25/2009 9:01:00 AM

    Covidien Announces Dividend Increase of 12.5%

    DUBLIN--(BUSINESS WIRE)--Sep. 25, 2009-- Covidien plc (NYSE: COV) today announced that its Board of Directors has declared a 12.5% increase in the quarterly dividend rate, from $0.16 per ordinary share to $0.18 per ordinary share. “Given our good operational performance thus far in 2009, our strong cash…